Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.
OCR for page 117
Assessing and Improving Value in Cancer Care: Workshop Summary Acronyms ACS American Cancer Society ASCO American Society of Clinical Oncology ASP average sales price ATC4 anatomical therapeutic classification AWP average wholesale price CCDR Canadian Coordinated Drug Review CED coverage with evidence development CMS Centers for Medicare and Medicaid Services FDA U.S. Food and Drug Administration GDP gross domestic product HTA health technology assessment ICD implantable cardiac defibrillator ICER incremental cost-effectiveness ratio IND investigational new drug IOM Institute of Medicine
OCR for page 118
Assessing and Improving Value in Cancer Care: Workshop Summary NCCN National Comprehensive Cancer Network NCI National Cancer Institute NCPF National Cancer Policy Forum NHS National Health Service (United Kingdom) NICE U.K. National Institute for Health and Clinical Excellence NIH National Institutes of Health NSCLC non-small cell lung cancer PBM pharmacy benefit manager PhRMA Pharmaceutical Research and Manufacturers of America QALY quality-adjusted life-year RCT randomized controlled trial RVU relative value unit VBID value-based insurance design